Your browser doesn't support javascript.
loading
Response to anti-IL17 therapy in inflammatory disease is not strongly impacted by genetic background.
Zhang, Cong; Shestopaloff, Konstantin; Hollis, Benjamin; Kwok, Chun Hei; Hon, Claudia; Hartmann, Nicole; Tian, Chengeng; Wozniak, Magdalena; Santos, Luis; West, Dominique; Gardiner, Stephen; Mallon, Ann-Marie; Readie, Aimee; Martin, Ruvie; Nichols, Thomas; Beste, Michael T; Zierer, Jonas; Ferrero, Enrico; Vandemeulebroecke, Marc; Jostins-Dean, Luke.
Afiliación
  • Zhang C; China Novartis Institutes for Bio-medical Research CO., Shanghai, China.
  • Shestopaloff K; Big Data Institute, Li Ka Shing Centre for Health Information and Discovery, Nuffield Department of Medicine, University of Oxford, Oxford, UK; Department of Statistics, University of Oxford, Oxford, UK.
  • Hollis B; Kennedy Institute of Rheumatology, University of Oxford, Oxford, UK.
  • Kwok CH; Nuffield Department of Population Health, University of Oxford, Oxford, UK.
  • Hon C; Novartis Institutes for BioMedical Research, 220 Massachusetts Avenue, Cambridge, MA 02139, USA.
  • Hartmann N; Novartis Pharma AG, Lichtstrasse 35, Basel, CH, Switzerland.
  • Tian C; China Novartis Institutes for Bio-medical Research CO., Shanghai, China.
  • Wozniak M; Novartis Ireland Limited, Dublin, Ireland.
  • Santos L; The Alan Turing Institute, London, UK.
  • West D; Radcliffe Department of Medicine, University of Oxford, Oxford, UK.
  • Gardiner S; Big Data Institute, Li Ka Shing Centre for Health Information and Discovery, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
  • Mallon AM; The Alan Turing Institute, London, UK.
  • Readie A; Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA.
  • Martin R; Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA.
  • Nichols T; Big Data Institute, Li Ka Shing Centre for Health Information and Discovery, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
  • Beste MT; Novartis Institutes for BioMedical Research, 220 Massachusetts Avenue, Cambridge, MA 02139, USA.
  • Zierer J; Novartis Institutes for BioMedical Research, Basel, CH, Switzerland.
  • Ferrero E; Novartis Institutes for BioMedical Research, Basel, CH, Switzerland.
  • Vandemeulebroecke M; Novartis Pharma AG, Global Drug Development, Basel, CH, Switzerland. Electronic address: marc.vandemeulebroecke@novartis.com.
  • Jostins-Dean L; Big Data Institute, Li Ka Shing Centre for Health Information and Discovery, Nuffield Department of Medicine, University of Oxford, Oxford, UK; Kennedy Institute of Rheumatology, University of Oxford, Oxford, UK. Electronic address: luke.jostins@kennedy.ox.ac.uk.
Am J Hum Genet ; 110(10): 1817-1824, 2023 10 05.
Article en En | MEDLINE | ID: mdl-37659414
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Artritis Reumatoide / Psoriasis / Artritis Psoriásica Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Am J Hum Genet Año: 2023 Tipo del documento: Article País de afiliación: China
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Artritis Reumatoide / Psoriasis / Artritis Psoriásica Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Am J Hum Genet Año: 2023 Tipo del documento: Article País de afiliación: China